SRTS - Sensus Healthcare price target raised by $3.50 at Alliance Global Partners, here's why
The Fly - Feb 09 09:40 EDT
Alliance Global Partners analyst Ben Haynor raised the firm's price target on Sensus Healthcare to $7.50 from $4 and keeps a Buy rating on the shares. Sensus reported Q4 results above the firm's estimates, and the company did an "admirable" job controlling operating expenses, the analyst tells investors in a research note. The big news was the announcement the company has launched a recurring revenue model, which the firm thinks will favorably alter perception even though the economics may not significantly impact the company until 2025 and beyond, the firm said.
I have seen lots of $1 stocks with strong earnings and solid balance sheets triple, quadruple and more, but I have yet to see one go below zero.
